close

Fenwick Represents BASIS Science in $11.5M Investment

March 06, 2013

Fenwick & West LLP represented BASIS Science, Inc​., a wrist-based health tracker and online personal dashboard that helps people adopt healthy habits, in its recently announced $11.5 million Series B investment. The round was led by Mayfield Fund, with existing participation from investors DCM and Norwest Venture Partners. As part of the investment, Tim Chang, Managing Director at Mayfield, has joined Basis’ board of directors.

The Fenwick transaction team was led by corporate partner Ted Wang; corporate of counsel In Lee; and corporate associate Ana Razmazma.